The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.
iShares Biotechnology ETF (IBB) trades at $209.54, down 0.95% on the day, as of Oct 23, 2026 00:41 UTC.
iShares Biotechnology ETF has a market capitalisation of $10.91B, calculated from the live IBB share price and shares outstanding.
iShares Biotechnology ETF generated revenue of $0.00 over the trailing twelve months.
IBB has traded between $153.25 and $217.12 over the past 52 weeks, and the last price is 3.5% below that high.
iShares Biotechnology ETF is classified under the Financial Services sector and the Asset Management industry, and is domiciled in US.
QFI Terminal shows IBB with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open IBB in Terminal See plans